218 related articles for article (PubMed ID: 28762136)
1. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.
Melin J; Parra-Guillen ZP; Hartung N; Huisinga W; Ross RJ; Whitaker MJ; Kloft C
Clin Pharmacokinet; 2018 Apr; 57(4):515-527. PubMed ID: 28762136
[TBL] [Abstract][Full Text] [Related]
2. Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency.
Whitaker MJ; Spielmann S; Digweed D; Huatan H; Eckland D; Johnson TN; Tucker G; Krude H; Blankenstein O; Ross RJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):1681-8. PubMed ID: 25646792
[TBL] [Abstract][Full Text] [Related]
3. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency.
Neumann U; Whitaker MJ; Wiegand S; Krude H; Porter J; Davies M; Digweed D; Voet B; Ross RJ; Blankenstein O
Clin Endocrinol (Oxf); 2018 Jan; 88(1):21-29. PubMed ID: 28815660
[TBL] [Abstract][Full Text] [Related]
4. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children.
Michelet R; Melin J; Parra-Guillen ZP; Neumann U; Whitaker JM; Stachanow V; Huisinga W; Porter J; Blankenstein O; Ross RJ; Kloft C
Eur J Endocrinol; 2020 Oct; 183(4):357-368. PubMed ID: 32621587
[TBL] [Abstract][Full Text] [Related]
5. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
[TBL] [Abstract][Full Text] [Related]
6. Immediate-release granule formulation of hydrocortisone, Alkindi®, for treatment of paediatric adrenal insufficiency (Infacort development programme).
Porter J; Withe M; Ross RJ
Expert Rev Endocrinol Metab; 2018 May; 13(3):119-124. PubMed ID: 30058902
[TBL] [Abstract][Full Text] [Related]
7. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.
Johannsson G; Bergthorsdottir R; Nilsson AG; Lennernas H; Hedner T; Skrtic S
Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806
[TBL] [Abstract][Full Text] [Related]
8. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
[TBL] [Abstract][Full Text] [Related]
10. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
Lennernäs H; Skrtic S; Johannsson G
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
[TBL] [Abstract][Full Text] [Related]
11. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
[TBL] [Abstract][Full Text] [Related]
12. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency.
Thomson AH; Devers MC; Wallace AM; Grant D; Campbell K; Freel M; Connell JM
Clin Endocrinol (Oxf); 2007 Jun; 66(6):789-96. PubMed ID: 17437510
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Charmandari E; Johnston A; Brook CG; Hindmarsh PC
J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
[TBL] [Abstract][Full Text] [Related]
14. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.
Prete A; Taylor AE; Bancos I; Smith DJ; Foster MA; Kohler S; Fazal-Sanderson V; Komninos J; O'Neil DM; Vassiliadi DA; Mowatt CJ; Mihai R; Fallowfield JL; Annane D; Lord JM; Keevil BG; Wass JAH; Karavitaki N; Arlt W
J Clin Endocrinol Metab; 2020 Jul; 105(7):2262-74. PubMed ID: 32170323
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP
Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
[TBL] [Abstract][Full Text] [Related]
18. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
19. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
[TBL] [Abstract][Full Text] [Related]
20. An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure.
Whitaker M; Debono M; Huatan H; Merke D; Arlt W; Ross RJ
Clin Endocrinol (Oxf); 2014 Apr; 80(4):554-561. PubMed ID: 23980724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
